Advertisement

Topics

Alexion price cut opens up Strensiq to more patients

10:24 EDT 5 Jul 2017 | pharmaphorum

NICE has recommended Strensiq in a wider group of patients with the ultra-rare disease paediatric-onset hypophosphatasia, after Alexion agreed a price cut. In February NICE published first draft guidance limiting the use of Strensiq (asfotase alf...

Original Article: Alexion price cut opens up Strensiq to more patients

NEXT ARTICLE

More From BioPortfolio on "Alexion price cut opens up Strensiq to more patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...